90
Views
0
CrossRef citations to date
0
Altmetric
Retraction

miR-132 Can Inhibit Glioma Cells Invasion and Migration by Target MMP16 in vitro [Retraction]

Pages 215-216 | Published online: 04 Mar 2022
This article refers to:
miR-132 can inhibit glioma cells invasion and migration by target MMP16 in vitro

Wang H, Li X, Wu C, Wu Z, Li Y, Yang T, Chen G, Xie X, Huang Y, Du Z, Zhou YX. Onco Targets Ther. 2015;8:3211–3218

The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised regarding alleged image duplication in Figure 2A and Figure 4. Specifically,

  • Figure 2A, panel U87 Normal appears to show duplication with parts of Figure 2A, panel U87 Pre-miR-132 NC.

  • Figure 2A, panel SHG44 Anti-miR-132 appears to show duplicated regions within the same image.

  • Figure 2A, panel A172 Pre-miR-132 appears to show duplicated regions within the same image.

  • Figure 2A, panel SHG44 Pre-miR-132 appears to show duplicated regions within the same image.

  • Figure 2A, panels U87 Normal and Anti-miR-132 NC appear to show duplicated regions with Figure 4A, panel U87 Mock from Yang et al (2014) (https://doi.org/10.1111/cas.12351).

  • Figure 2A, panel U87 Anti-miR-132 appears to show duplication with parts of Figure 4A, panel U87 Negative from Yang et al (2014) (https://doi.org/10.1111/cas.12351).

The authors were contacted and did provide an explanation for the duplicated images, but it was not satisfactory. In addition, the authors did provide some original data but again it was not satisfactory, and the findings of the paper were deemed to be invalid.

Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”.